The American Journal of Managed Care

Lower Odds of Cataract Associated With Antioxidant Index

Higher CDAI measurements correlate with reduced cataract risk in adults over 50, with a 4% decrease in odds per unit increase in CDAI. The study utilized NHANES data from 2003-2008, including 5814 ...
Nasdaq

Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months

SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced ...
The New England Journal of Medicine

Sargramostim for Active Crohn's Disease

Sargramostim, granulocyte–macrophage colony-stimulating factor, a hematopoietic growth factor, stimulates cells of the intestinal innate immune system. Preliminary studies suggest sargramostim may ...
Snopes.com

Did a New Study Show That Marijuana Leads to a Complete Remission of Crohn's Disease?

Since 2013, viral stories have parroted (with the aid of copy, paste, and lax editorial standards) details of a single, 22-person pilot clinical trial on the use of cannabis as a treatment for Crohn's ...
Lupus Foundation of America

Study Leads to a New Approach for Evaluating the Effectiveness of Experimental Therapies

A Lupus Foundation of America study has led to the development of a new model for assessing patient outcomes in clinical trials. The new model, based on findings from the Lupus Foundation of America’s ...